Skip to content
The Policy Vault
Methodology
Why
Contact
Coverage
/
Medica
/
Eliquis tablets for oral suspension
/
Venous thromboembolic events (to reduce the risk of recurrence)
← Back
Eliquis tablets for oral suspension — Medica
Venous thromboembolic events (to reduce the risk of recurrence)
Initial criteria
Patient weighs < 35 kg
Approval duration
1 year